Radical prostatectomy, hormonal therapy and radiation are conventional techniques for eradicating prostate cancer. When surgery is not a therapeutic choice, or tumour does not respond to hormonal therapy with local symptoms on the primary or metastatic foci, radiation is used as the last treatment line for these patients. Our approach for increasing the radiosensitisation of prostate tumour cells is based on the overexpression into the tumour cells of the bacterial enzyme cytosine deaminase (CD) by gene transfer techniques. This enzyme (CD) can speci®cally transform the non-toxic pro-drug 5-urocytosine (5-FC) into the toxic compound 5-¯uorour-acil (5-FU). It is well established that 5-FU is an enhancer radiosensibilisator.
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Method
Our work hypothesis is based on the generation of high intracellular concentrations of 5-FU by infecting the prostate tumour cells with a defective recombinant adenovirus containing the CD gene. After infection and exposure to the non-toxic prodrug 5-FC, we will test if the 5-FU generated into the tumour cells enhances the toxicity of the parental cell lines to radiation, or to exogenous 5-FU administration plus radiation.
Results
Preliminary results obtained in our laboratory demonstrate that in several prostate cancer cell lines the expression of the CD gene plus 5-FC generates higher toxicities than 5-FU alone. These results show that the intracellular generation of 5-FU can be more effective than the exogenous administration of 5-FU. Different experiments are underway in the laboratory to test the susceptibility of several prostate tumour cells infected with the recombinant adenovirus containing the CD gene to radiotherapy.
Work has been done on three different cell lines and results on DU-145 will be presented.
